Calmasol 250P

Indications

• Dietary supplement
• Phosphate metabolism disorders
• Potential antioxidant therapy

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Dosage varies based on indication, refer to BNF for specific dosing guidelines.

Mechanism of action

Hypophosphite acts as a reducing agent, donating electrons in various biochemical reactions. It is involved in the synthesis of nucleotides and nucleic acids, thereby playing a role in energy metabolism and cellular function. The reducing properties of hypophosphite facilitate the conversion of reactive oxygen species, potentially providing protective effects against oxidative stress.

Pharmacodynamics

Hypophosphite exhibits its pharmacological effects primarily through its role in phosphate metabolism and as an electron donor. Its antioxidant properties may help mitigate oxidative damage in tissues. Moreover, hypophosphite has been studied for its potential effects on enhancing immune function and promoting cellular repair and regeneration.

Pharmacokinetics

The pharmacokinetics of hypophosphite is not extensively characterized in literature. However, it is known to be absorbed in the gastrointestinal tract when taken orally. The compound is distributed throughout the body, particularly in tissues where phosphate metabolism occurs. The elimination of hypophosphite is primarily via renal excretion, as it is filtered through the kidneys.

Pregnancy

There is limited data on the use of hypophosphite in pregnancy. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

Hypophosphite is not known to be excreted in human milk. Caution is advised when administering to breastfeeding women.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.